GE HealthCare (GEHC) Technologies announced the launch of a secondary underwritten public offering of 13.28M shares of its common stock. GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the offering or from the debt-for-equity exchange. Prior to the closing of the offering, GE Aerospace is expected to exchange the GEHC shares for indebtedness of GE Aerospace held by Morgan Stanley Bank, an affiliate of Morgan Stanley & Co., the selling stockholder in the offering by designation of the MS Lender. Following the debt-for-equity exchange, if consummated, Morgan Stanley & Co., as the selling stockholder in the offering, intends to sell the GEHC shares to the underwriters in the offering. J.P. Morgan, Citigroup and Morgan Stanley are acting as the lead joint book-running managers for the offering.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare price target raised to $97 from $95 at Piper Sandler
- GE HealthCare price target raised to $96 from $95 at Wells Fargo
- GE HealthCare Technologies Inc. Announces Q3 2024 Results
- Morning Movers: Caterpillar and Eli Lilly sink following quarterly reports
- GE Healthcare Restructures to Enhance Imaging Solutions